Company Filing History:
3 out of 6 
3 out of 24 
Years Active: 2013-2015
Title: Etsuro Matsubara: Innovator in Alzheimer's Disease Research
Introduction
Etsuro Matsubara is a prominent inventor based in Aomori, Japan. He has made significant contributions to the field of Alzheimer's disease research through his innovative work in monoclonal antibodies. With a total of 3 patents, Matsubara's inventions focus on the development of diagnostic and therapeutic tools for this debilitating condition.
Latest Patents
Matsubara's latest patents include groundbreaking work on antibodies that specifically bind to Aβ oligomers. These monoclonal antibodies are designed to recognize only soluble Aβ oligomers while avoiding soluble Aβ monomers, which are physiological molecules. This specificity demonstrates their potential utility as diagnostic and therapeutic agents for Alzheimer's disease.
Career Highlights
Throughout his career, Etsuro Matsubara has worked with notable organizations such as Immunas Pharma, Inc. and the National Center for Geriatrics and Gerontology. His research has been pivotal in advancing our understanding of Alzheimer's disease and developing effective treatments.
Collaborations
Matsubara has collaborated with esteemed colleagues, including Masao Shibata and Tatsuki Yokoseki. These partnerships have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Etsuro Matsubara's work in the field of Alzheimer's disease research exemplifies the impact of innovation in medicine. His patents and collaborations highlight the importance of targeted therapies in addressing complex health challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.